SEO tips to get first rank on googleBy: drmony
SEO tips to get first rank on google
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|Getting your website to come up top on Google can be very beneficial for your business. Making a website to come up first on Google is not hard - you just need to know the steps to optimize your website correctly.|
SEO (search engine optimization) is the process of improving the volume and quality of the traffic to a website from search engines organic search result listings. Let me share with you some tips to make your website come up first:
1. Clean website coding and architecture. Before you start optimizing your website, you need to have a search engine friendly design. The coding of your website must also be clean so that Google robots can read and understand what your website is about. Avoid using Flash or Frames to build your website as this will prevent Google to read your site properly.
2. Set up internal linking on your website. Internal linking is very important to tell Google which page is important. Therefore, always place text links within your content and point to other important pages on your site. Also, use keywords as your anchor text to increase keyword weight. For example, if you want to point to a page that describes your car rental service, use "car rental service" as the anchor text instead of "click here".
3. Build back links to your website. With more back links pointing to your site, it tells Google that your site is important. Build more back links through article marketing, press release submission, directory submission and social book marking.
4. Post good content on your website. Content is king in SEO. With good content, people will start linking back to your website so that they can share your content with their readers. A website with good content is a link bait and attract lots of back links to your site.
5. Let your site age. The age of your domain name matters when it comes to SEO. Although it is possible for a new website to come up first on Google, older pages are more respected by Google. Especially older pages with high PR (PageRank), it is easier for them to rank high for competitive keywords when compared to newer pages.
SEO is the bed rock of online marketing. Every website should implement SEO right from the beginning. When done right, search engines will bring targeted visitors that will help increase your website conversion.
||Fitness Program,fitness beauty,fitness care
||Health and Fitness
||Jul 27, 2009
|Article Contact Name
||drmony || send email to drmony
Other links at Health and Fitness
BRIC & Eastern European Nations Lead Global Pharma Sector amidst Recession
With increasing lifestyle-related ailments, improvement in life expectancy rate and soaring healthcare spending worldwide, the global pharmaceutical market is projected to generate revenue of nearly US$ 1043.4 Billion by 2012, said RNCOS new research report “Global Pharmaceutical Market Forecast to 2012”.
According to a Senior Research Analyst at RNCOS, the global pharmaceutical market will not see much impact of ongoing global economic meltdown as it is considered the recession proof industry. However, the sales of some chronic and OTC drugs have slightly plunged as people cut down spending on medicines following the impact of economic meltdown on their pocket.
Under the current scenario, the growth of pharmaceutical market in developed countries will slowdown, but it will sustain in emerging markets. The US (world’s largest pharmaceutical market) posted the slowest growth in several decades, whereas the BRIC countries (Brazil, Russia, India and China) along with some eastern European countries registered sustained double-digit growth. Thus, pharmaceutical manufacturers are focusing on these countries to keep rolling their businesses.
The global pharmaceutical market is gaining growth momentum all around the world, creating immense opportunities for various players to expand their business operations. It will open new growth avenues in different areas such as clinical trial market, RFID market, pharmaceutical packaging market, medical devices, logistics devices and health insurance.
“Global Pharmaceutical Market Forecast to 2012” provides comprehensive and qualitative analysis on major pharmaceutical markets all around the globe, with focus on both current and past trends. The report enables pharmaceutical manufacturers/investors/consultants studying the global pharmaceutical market to identify and analyze growth opportunities that will suit their business requirements and profiles. It also gives forecasts on various segments of pharmaceutical market along with healthcare statistics by countries.
The extent of information covered in the report will help clients to comprehend the industry dynamics and the corresponding factors responsible for transformation of the industry.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM149.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
RNCOS Releases a New Report - Market Potential for Hospital Services, Pharmaceuticals and Medical De
RNCOS has recently added a new Market Research Report titled, “Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US”, to its report gallery. The US, with its healthcare spending crossing US$ 2.2 Trillion in 2007, represents the most important healthcare product and services market in the world. And according to “Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US”, the new research report from RNCOS, the potential and opportunities in this market are expected to increase several fold in the next five years.
This report provides factual insight supplemented with statistical overview on the past, present and future market. It studies the entire structure, composition and working of the US healthcare sector and describes the potential of hospital services, pharmaceuticals and medical devices in the market. This report discusses the demand, market size and future prospects of nearly every major sector, like cardiovascular, diabetes, musculoskeletal, oncology, wound care management, cosmetic surgery, dental health, and in vitro diagnostics, in the US healthcare market. It identifies key opportunities and roadblocks that will affect the future direction of the market.
The report thus serves as a guide for healthcare service providers/drug manufactures/investors who are planning to enter the US healthcare market as it helps in identifying and analyzing market opportunities that will suit their business needs and profiles.
Key Findings of the Report
- Total healthcare spending in the US is expected to grow at a CAGR of 7% between 2007 and 2012.
- Around 43 Million people are expected to be above 65 years of age in the US by 2012, thereby increasing the prevalence of several chronic diseases.
- Around 122 Million Americans are expected to suffer from cardiovascular diseases by 2012, leading to direct expenses of over US$ 414 Billion.
- The US, with over 19 Million diabetics by 2012, is expected to fuel the growth of the diabetes drugs and monitoring devices market.
- Driven by target-based therapies with negligible side effects, the US oncology market is amongst the fastest growing sectors in the healthcare industry.
- The aging baby boomers, coupled with an increasing incidence of hip and knee fractures, are expected to strongly drive the musckoskeletal market.
- Driven by a need to look young and attractive, both surgical and non-surgical cosmetic procedures are becoming highly popular.
Key Issues & Facts Analyzed in the Report
- Evaluation of past, current and future market trends.
- Market evaluation by type of disease.
- Discussion on the major drivers of the healthcare market.
- Identification and evaluation of the opportunities created by the market.
- Analysis of major challenges for the market.
Research Methodology Used in the Report
Information has been sourced from books, newspapers, trade journals, white papers, industry portals, government agencies, trade associations, monitoring industry news and developments, and through access to over 3000 paid databases.
RNCOS industry forecast and analysis is based on various macro- and microeconomic factors, sector and industry specific databases, and our in-house statistical and analytical model. This model takes into account the past and current trends in an economy, and more specifically in an industry, to bring out an objective market analysis.
Our industry experts study the relationship between various industry and economic variables to ensure the required accuracy and desired check on the quality of data and information given in the report.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM147.htm
Check DISCOUNTED REPORTS on http://www.rncos.com
Aging Population & Healthcare Reforms Driving Russian Pharma
According to our new research report, “Russian Pharma Sector Analysis”, the pharmaceutical market in Russia has very bright future as it will grow at a CAGR of nearly 14% by 2012. The positive outlook for pharmaceutical market is based on the high proportion of elder people (65 years and above) in the overall population.
The proportion of aging population in Russia mounted to 20.4 Million in 2007 from 18.5 Million in 2001, indicating to the enormous growth opportunities for the pharmaceutical industry, said the RNCOS report. Moreover, the share of aging population is anticipated to further rise with the improvement in the Russian healthcare system.
With expanding share of aging population, the prevalence of age-related diseases such as arthritis, diabetes and heart ailments is also increasing that will fuel the demand for medicines used in the treatment of these diseases. The dependency ratio of aged people on the working population is also growing with rising number of senior citizens in the country.
Besides, the reforms introduced by the Russian government in the healthcare sector have given fresh impetus to the pharmaceutical sector. Poor state of the healthcare system and declining population have prompted the government to reform the healthcare system and increase spending.
“Russian Pharma Sector Analysis” provides comprehensive research and objective analysis on the growing demand for pharmaceuticals in Russia. It discusses present and past trends to give clear picture of the country’s healthcare and pharmaceutical market. The report also provides brief overview of major players operating in each segment of the market along with the shares of imported and domestic drugs. Rx, OTC and sales structure by ATC group have been analyzed in the context of the Russian pharmaceutical market.
The report also provides forecast on various segments of Russian Pharma Sector, including pharmaceutical market by segments, population aged 65 years & above, commercial drugs segment.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM548.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
Discover the true meaning of yoga With Swami Ramdev
In taking any modern yoga class, you will find parallels to ballet. Like ballet, the promise of poise, grace and flexibility encourages much interest. Yet if yoga is like any other exercise, it is only at first glance. Underneath the coveted health and fitness benefits of modern yoga practice are the roots of a great spiritual tradition blending cultures and religions.
Asanas urge us to see our body as divine, and to nurture health in this mortal temple. Yogic adepts understand that their body is flawed, however slender and toned it may look externally. This acknowledgement leads to less judgement of otherâ��s bodies. However pleasing to the eye a yogis shape may be, the same vedic texts that encourage the practice of yoga for health, also remind us that true â��liberationâ�� comes from being free of the cycle of rebirth-free of the physical form.
Yogic postures work in contrast to the western notion of exercise. Here we see exercise as an end, such as an end to overweight and fatigue. Yoga is different. While in most forms of exercise the physical results are the sole goal, in yoga the soul is the goal. The ancient tradition of yoga exercise stands apart in its doctrines. The ancient yoga texts insist that the mind and spirit are more important than the physical body. While many other eastern forms of mind-body fitness also encourage this awareness, no other physical practice has the ultimate goal of union with the divine. In yoga, the process of attaining this union is as important as the actual attainment.
Yoga practice is not a means to an end. It is an end in of itself. Even distinguished from vedas and sutras, the modern practice of yoga posture is a beautiful and calming pursuit. Though modern yoga practice makes little mention of the scriptures that it is based on, the experience of union and compassion can be woven into each pose. In doing this we are enhancing more than our practice, we are improving our life.
Yoga With Swami Ramdev
Swami Ramdev Born in year 1974 also known as Baba Ramdev is in fact an Indian Hindu swami and an passionate admirer of Swami Vivekananda and Netaji Subhas Chandra Bose. He is mainly well-known for his efforts into popularizing Yoga Practices in different part of world. He is as well one of the founders of the Divya Yoga Mandir Trust that aims to popularize Yoga and offer Ayurvedic treatments.
His camps are also attended by a great number of people. Over 85 million people follow his particular yoga camps via TV channels, and video. Yoga practice is not a means to an end. It is an end in of itself. Even distinguished from vedas and sutras, the modern practice of yoga posture is a beautiful and calming pursuit His yoga teaching sessions are great for the masses and so free for all. His stated main principle in life that is to be of help to all casts members. The sessions are conducted with the minimal to excessive charges, and depending on the place where the camp that is also being offered.
RNCOS Releases a New Report- Japanese Generic Market Forecast to 2013
According to “Japanese Generic Market Forecast to 2013”, a new research report by RNCOS, Japan promises to be one of the most lucrative generic markets in the world. Between 2005 and 2008, the Japanese generics market grew at a CAGR of around 7.5% to register ¥ 333 Billion (US$ 3.5 Billion) in revenue.
The Japanese market is characterized by a strong support by the government, which in a desperate bid to limit its healthcare costs, is introducing a number of generic-friendly policies. Other factors such as a large number of patent expiries and the largely un-penetrated nature of the market are also contributing towards the market growth.
The generic market is presently dominated by domestic manufacturers, with the top six manufacturers accounting for 56% of the total market in 2007. But opening up of the market and introduction of a number of generic-friendly reforms is attracting a number of foreign players in the market.
Despite such a big opportunity for future, the market also has a number challenges to deal with. Generic drugs are still regarded as cheap, low quality alternatives of branded drugs. Thus, both physicians and patients are skeptic regarding their safety and efficacy. A number of awareness and educational programs, however, are expected to increase their awareness in future.
Despite these challenges, our forecast models suggest that the generic drugs market will grow at a CAGR of around 8.8% between 2009 and 2013.
The report gives an extensive and objective analysis on the generic market in Japan. It investigates both the past and present trends in the generic market, but its focus is on the future trends shaping the industry. The report also investigates the performance of various players in the Japanese pharmaceutical and generic markets, and analyzes the competitive landscape in these markets. Based on various present and future indicators, the future scenario of the market has also been analyzed.
Key questions answered in the report
- What is the size and penetration level of the Japanese generic market?
- How is the Japanese generic market different from other developed markets?
- What are the key drivers and challenges for the generic market?
- What is the role of government in the market?
- What is the viewpoint of patients and physicians on generic drugs?
- What is the future outlook of the drug market?
- Who are the key players operating in the Japanese generic market?
Key players operating in Japanese generic market
This report features the key players currently operating in the Japanese pharmaceutical and generic markets. This section describes market shares and growth of key pharmaceutical and generic players in Japan. Profiles of the top six generic manufacturers have been provided in the report.
For more information visit: http://www.rncos.com/Report/IM170.htm
Current Industry News: http://www.rncos.com/Blog/